Thursday, January 15, 2026

Watermelon(Cardiovascular Protection)

   Watermelon(Cardiovascular 

Protection

Cardiovascular diseases are the leading cause of increasing death rate worldwide. Moreover, the cost of treating cardiovascular disease are high. Therefore, adapting a lifestyle with cardio-friendly diet would decrease the risk factors associated with the disease. Fruits and vegetables can combat the negative effects of cardiovascular diseases. l-citrulline and l-arginine possess the capacity to alleviate the inflammation and oxidative stress [19,20]. However, direct intake of l-citrulline and l-arginine could lead to gastro-intestinal discomforts such as nausea and diarrhea [21,22]. Therefore, the consumption of fruits rich in l-citrulline (precursor of l-arginine, an essential amino acid for protein synthesis)—such as watermelon—is important to obtaining the necessary nutrition. Supplementation of whole watermelon in powder form improved the lipid profiles, antioxidant status, and anti-inflammatory properties of high fat fed rats [23]. Moreover, the ingestion of watermelon regulated the expression of genes associated with lipid metabolism [23]. In detail, the augmentation of watermelon and l-arginine enhanced the regulation of hepatic gene expression of endothelial nitric oxide synthase. Nitric oxide (NO) is a ubiquitous signaling molecule vital for the relaxation of blood vessels and it also reduces the atherosclerosis by influencing the lipid metabolism [23,24,25]. On the other hand, watermelon supplementation down-regulated the genes involved in lipid metabolism such as fatty acid synthase (FAS), 3-hydroxy-3methyl glutaryl-coA reductase (HMGCR), sterol regulatory element binding protein (SERB) 1, SERB 2, cyclooxygenase-2 (COX2), and nuclear factor-kB (NF-κB) in rats [23]. Among the above enzymes, FAS plays an important role in the denovo synthesis of fatty acids, whereas HMGCR acts as a rate limiting enzyme in cholesterol synthesis [26]. Similarly, both SREBP-1 and SREBP-2 regulate the transcription of genes involved in fatty acid and cholesterol synthesis respectively [27].


Oxidative stress and inflammation are the key players in the onset of atherosclerosis. The serum C-reactive protein levels are utilized as the indicators of systemic inflammation which leads to cardiac dysfunction [28,29]. Watermelon intake significantly reduced the levels of C-reactive protein levels in the serum of high fat fed rats [30]. Moreover, watermelon also down-regulated the expression of Cox-2 enzyme responsible for the synthesis of pro-inflammatory prostaglandins. Furthermore, Hong et al. [30], illustrated that the watermelon supplementation exhibited similar mechanism to non-steroidal anti-inflammatory drugs that inhibits the activity of Cox-2 and reduces the inflammatory response. A recent study has demonstrated the ability of watermelon to reduce the risk factors of cardiovascular disorder in human [31,32]. According to Connolly et al. [32], consumption of watermelon in daily basis for a period of four weeks resulted in significant reductions in body weight, body mass index, waist-to-hip ratio, and blood pressure. In addition, the report also claims that the watermelon supplementation lowered the levels of triglyceride, low density lipoprotein cholesterol, thiobarbituic acid reactive substance, and increased the antioxidant capacity in obese adults [32]. Overall, it has been evident that the consumption of watermelon in regular basis reduces the risk factors associated with chronic illnesses such as cardiovascular diseases.


Ref

Molecules

. 2020 Nov 11;25(22):5258. doi: 10.3390/molecules25225258

Versatile Nutraceutical Potentials of Watermelon—A Modest Fruit Loaded with Pharmaceutically Valuable Phytochemicals

No comments:

Post a Comment